Clinical Predictors of Response to Treatment with Tofacitinib (Janus Kinase Inhibitor) in Patients with Ankylosing Spondylitis. IJBR [Internet]. 2025 Apr. 15 [cited 2025 Aug. 14];3(4):175-81. Available from: https://ijbr.com.pk/IJBR/article/view/1020